Regeneus Ltd chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 0.00
Dividend & YieldN/A$ (N/A)
Beta -0.13
Market capitalization 15.02M
Operating cash flow -3.92M
ESG Scores unknown

Company description

Regeneus Ltd, a clinical-stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, and neuropathic pain and dermatology diseases in Australia. Its lead platform technology includes Progenza, a cryopreserved multi-synergistic therapy for the treatment of osteoarthritis and neuropathic pain. The company also develops Sygenus for the treatment of skin wound healing. Regeneus Ltd was incorporated in 2007 and is headquartered in Paddington, Australia.

Sector: Healthcare - Industry: Biotechnology

Financial data

Financial Statements

Cashflow Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Change To Liabilities 400.36k 1.28M 1.35M -1.36M
Total Cashflows From Investing Activities -150.97k -7.62k 16.18k -7.78k
Net Borrowings 1.35M 2.78M -1.25M -1.1M
Total Cash From Financing Activities 1.35M 2.78M 2.63M 400k
Change To Operating Activities 160.52k 241.88k 692.31k -314.56k
Issuance Of Stock 3.88M 3.88M 3.88M 1.5M
Net Income -5.18M -6.02M -894.05k 2.76M
Change In Cash -3.04M -836.12k 726.38k 2.81M
Effect Of Exchange Rate
Total Cash From Operating Activities -4.25M -3.61M -1.92M 2.42M
Depreciation 343.85k 269.14k 73.97k 54.12k
Change To Account Receivables 770 -1.47M -1.47M 1.47M
Other Cashflows From Financing Activities
Change To Netincome 21.34k 620.51k -1.69M -189.83k
Capital Expenditures -150.97k -7.62k -7.78k -7.78k

Income Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Research Development 3.96M 2.43M 1.24M 1.44M
Income Before Tax -5.18M -6.02M -894.05k 2.76M
Net Income -5.18M -6.02M -894.05k 2.76M
Selling General Administrative 3.94M 4.44M 3.7M 3.99M
Gross Profit 2.78M 1.44M 2.33M 7.92M
Ebit -5.12M -5.42M -2.56M 2.49M
Operating Income -5.12M -5.42M -2.56M 2.49M
Interest Expense -2.35k -320.93k -248.68k -45.09k
Income Tax Expense
Total Revenue 2.78M 1.44M 2.33M 7.92M
Cost Of Revenue
Total Other Income ExpenseNet -65.71k -604.78k 1.66M 271.91k
Net Income From Continuing Ops -5.18M -6.02M -894.05k 2.76M
Net Income Applicable To Common Shares -5.18M -6.02M -894.05k 2.76M

Balance Sheet Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Total Liabilities 2.06M 8.93M 3.7M 4.36M
Total Stockholder Equity 2.92M -6.39M 1.09M 4.15M
Other Current Liabilities 68.97k 3.83M 1.47M 90.18k
Total Assets 4.98M 2.54M 4.79M 8.51M
Common Stock 31.08M 31.08M 36.36M 38.26M
Other Current Assets 38.74k 210k
Retained Earnings -29.77M -37.88M -37.49M -34.65M
Treasury Stock 1.62M 412.06k 2.23M 535.38k
Cash 1.09M 255.46k 981.85k 3.79M
Total Current Liabilities 1.82M 8.75M 3.63M 1.3M
Other Stockholder Equity 1.62M 412.06k 2.23M 535.38k
Property, Plant, and Equipment 417.25k 153.45k 80.17k 33.84k
Total Current Assets 4.31M 2.38M 3.48M 6.73M
Net Tangible Assets 2.92M -6.39M 1.09M 4.15M
Net Receivables 3.12M 1.9M 2.49M 1.41M
Accounts Payable 372.16k 391.31k 555.76k 872.38k


Insider Transactions

Here are the insider transactions of stock shares related to Regeneus Ltd:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Vesey (Graham)Other at price 0.03 per share.D2022-06-10Director (Executive)1.11M
Rosickas (Karolis)Purchase at price 0.03 per share.D2022-06-10Chief Executive Officer3.84M
Lee (Leo Yao)Purchase at price 0.13 per share.D2020-09-01Chief Executive Officer2.38M
Richards (Glen Frank)D2020-06-04Former3.04M
Richards (Glen Frank)Other at price 0.05 per share.D2019-09-03Director (Independent)1.88M
Sechos (Barry George)D2019-09-03Director (Non-Executive)1.25M
Lee (Leo Yao)Other at price 0.05 per share.D2019-09-03Independent Non-Executive Director12.5M
Aston (Roger)D2019-04-29Former51.18k
Martin (John Dominic)D2019-04-29Former3.49M
Lee (Leo Yao)Purchase at price 0.09 per share.D2018-04-19Independent Non-Executive Director1.01M
Sechos (Barry George)Purchase at price 0.10 per share.D2017-03-09Director (Non-Executive)200k
Martin (John Dominic)D2015-06-30Chief Executive Officer180k
Aston (Roger)Purchase at price 0.15 per share.D2015-06-03Non Executive Chairman51.18k
Martin (John Dominic)D2014-11-06Chairman of the Board204.62k
Vesey (Graham)Other at price 0.22 per share.D2014-11-06Chief Executive Officer384.62k
Herbert (Benjamin Ross)I2014-06-30Director (Non-Executive)

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Regeneus Ltd. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Regeneus Ltd

Here is the result of two systematic investment strategies applied to Regeneus Ltd. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Regeneus Ltd

The following chart shows the equity curve of the two systematic investment strategies applied to Regeneus Ltd:

Regeneus Ltd automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -6.12% on the backtest period.

Performance at glance

Performance

-6.12 %

Latent gain

-137.68 $

Invested capital

2250.07 $

Annualized return

-1.34 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Regeneus Ltd

This is the result of two momentum investment strategies applied to Regeneus Ltd. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Regeneus Ltd

The following chart shows all the entries opened by the momentum investment system on Regeneus Ltd:

Regeneus Ltd momentum entries
  • The first momentum investment strategy would give 15.45% of return on Regeneus Ltd. That represents 1081.24$ of latent gain with 7000.09$ of employed capital.
  • The second momentum investment strategy would give 15.53% of return on Regeneus Ltd. That represents 854.09$ of latent gain with 5499.99$ of employed capital.
Performance at glance (1Q Momentum)

Performance

15.45 %

Latent gain

1081.24 $

Invested capital

7000.09 $

Annualized return

10.36 %
Performance at glance (2Q Momentum)

Performance

15.53 %

Latent gain

854.09 $

Invested capital

5499.99 $

Annualized return

3.81 %

Momentum equity curve on Regeneus Ltd

The following chart shows the equity curve of the two momentum strategies applied to Regeneus Ltd:

Regeneus Ltd momentum equity

Note: the dividends potentially given by Regeneus Ltd are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Regeneus Ltd

The following chart shows the employed capital evolution of the two momentum strategies on Regeneus Ltd since the beginning:

Regeneus Ltd

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Regeneus Ltd

Buy the dip entry openings on Regeneus Ltd

Regeneus Ltd

The performance achieved by the robo-advisor on Regeneus Ltd is 26.51%. That represents 66.26$ of latent gain with 250.0$ of employed capital. The following chart shows Regeneus Ltd stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Regeneus Ltd, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

26.51 %

Latent gain

66.26 $

Invested capital

250.0 $

Annualized return

10.36 %

Equity curve of the strategy applied to Regeneus Ltd

The following chart shows the result of the investment strategy applied to Regeneus Ltd:

Regeneus Ltd

Note: the dividends potentially given by Regeneus Ltd are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Regeneus Ltd

The following chart shows the employed capital evolution since the beginning of the investment strategy on Regeneus Ltd:

Regeneus Ltd

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Regeneus Ltd

In this section, I will compare the three previous investment strategies applied to Regeneus Ltd.

Equity curve comparison on Regeneus Ltd

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Regeneus Ltd investment strategy comparison

Employed capital comparison on Regeneus Ltd

Regeneus Ltd investment comparison

Performance comparison on Regeneus Ltd

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -6.12% -137.68$ 2250.07$ -1.34%
Momentum 1 quarter 15.45% 1081.24$ 7000.09$ 3.58%
Momentum 2 quarters 15.53% 854.09$ 5499.99$ 3.81%
Non-directional 26.51% 66.26$ 250.0$ 10.36%
Annualized return comparison

Automatic investment

-1.34 %

Momentum 1Q

3.81 %

Momentum 2Q

3.81 %

Non-directional

10.36 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Regeneus Ltd:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Regeneus Ltd and the other stocks. There may be false positives or some missing correlated stocks. If the price of Regeneus Ltd does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Regeneus Ltd
Country Australia
City Paddington
Address 2 Paddington Street
Phone 61 1300 995 098
Website regeneus.com.au
FullTime employees
Industry Biotechnology
Sector Healthcare
Exchange XASX
Ticker RGS.XASX
Market www2.asx.com.au

Regeneus Ltd ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown